A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. (Q47319669)
Jump to navigation
Jump to search
scientific article published in March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. |
scientific article published in March 2016 |
Statements
1 reference
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. (English)
1 reference
1 reference
Saswata Talukdar
1 reference
Yingjiang Zhou
1 reference
Dongmei Li
1 reference
Michelle Rossulek
1 reference
Jennifer Dong
1 reference
Veena Somayaji
1 reference
Yan Weng
1 reference
Ronald Clark
1 reference
Adhiraj Lanba
1 reference
Martin B Brenner
1 reference
Jeffrey K Trimmer
1 reference
Kathryn E Gropp
1 reference
Jeffrey R Chabot
1 reference
Derek M Erion
1 reference
Timothy P Rolph
1 reference
Bryan Goodwin
1 reference
Roberto A Calle
1 reference
1 March 2016
1 reference
1 reference
23
1 reference
427-440
1 reference
3
1 reference
Identifiers
1 reference
1 reference